SEK0.002 0.0 0.0%
Last Trade - 29/01/20
| Market Cap | £12.5m |
| Enterprise Value | £9.41m |
| Revenue | £1.23m |
| Position in Universe | th / 1838 |
| Industry | Market | |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| Year End 31st Dec | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021E | 2022E | CAGR / Avg | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.000 | 3.04 | 6.86 | 11.2 | 45.2 | 14.6 | |||||
|
x
|
||||||||||
| Profitability | ||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
| Cashflow | ||||||||||
| Dividends | ||||||||||
| Balance Sheet | ||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing % | |||
| Net Gearing % | |||
| Cash / Assets % |
| Liquidity (ttm) | ||
|---|---|---|
| Curr. Ratio | ||
| Quick Ratio | ||
| Interest Cov. | ||
| Efficiency (ttm) | ||
|---|---|---|
| Asset Turnover | ||
| Recs Turnover | ||
| Stock Turnover | ||
| Latest interim period vs. prior period | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
| 3yr Compound Annual Growth Rate | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
Revenue
Net Income
Normalised EPS
PE Ratio Range
Dividend Yield Range
|
Price Target:
( below Price)
|
31st Dec 2021
|
31st Dec 2022
|
||||
|---|---|---|---|---|---|---|
| Est. Long Term Growth Rate: |
Net Profit () |
EPS () |
DPS () |
Net Profit () |
EPS () |
DPS () |
| Consensus Estimate | ||||||
| 1m Change | ||||||
| 3m Change | ||||||
ChromoGenics AB is a Sweden-based company, which develops, manufactures and markets foil-based products with controllable optical properties and conducts related business. The Company’s primary product is ConverLight, which is an electrochromic glass with dynamic solar control properties. This glass enables control of light influx to tone down the light and energy admission in various parts of property or premises. The glass is suitable for new construction, reconstruction and renovation and offers ultraviolet protection that reduces risk of fading interiors. The Company distributes ConverLight to commercial installation companies in Sweden and Norway. The main shareholders in the Company are K-Svets Venture AB and New Energy Solutions II K/S.
| Last Annual | December 31st, 2020 |
| Last Interim | December 31st, 2020 |
| Public Since | March 23, 2017 |
| No. of Shareholders: | n/a |
| No. of Employees: | n/a |
| Sector | Consumer Cyclicals |
| Industry | Homebuilding & Construction Supplies |
| Index | |
| Exchange | OMX Nordic Exchange Stockholm (Dual Listing) |
| Shares in Issue | 16,976,019 |
| Free Float | (0.0%) |
| Eligible for |
ISAs
SIPPs
|
| Address | Ullforsgatan 15, UPPSALA, 752 28, Sweden |
| Web | https://www.chromogenics.com/ |
| Phone | +46 18 4300430 |
| Contact | () |
| Auditors | Grant Thornton Sweden AB |
As of 29/01/20, shares in ChromoGenics AB are trading at SEK0.002, giving the company a market capitalisation of £12.5m. This share price information is delayed by 15 minutes.
Shares in ChromoGenics AB are currently trading at SEK0.002 and the price has moved by -94.37% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the ChromoGenics AB price has moved by -95.27% over the past year.
There are no analysts currently covering ChromoGenics AB.
ChromoGenics AB is scheduled to issue upcoming financial results on the following dates:
ChromoGenics AB does not currently pay a dividend.
ChromoGenics AB does not currently pay a dividend.
ChromoGenics AB does not currently pay a dividend.
To buy shares in ChromoGenics AB you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
Shares in ChromoGenics AB are currently trading at SEK0.002, giving the company a market capitalisation of £12.5m.
Here are the trading details for ChromoGenics AB:
We were not able to load our ranking data for ChromoGenics AB
We were not able to load any forecast data for ChromoGenics AB.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like ChromoGenics AB. Over the past six months, the relative strength of its shares against the market has been -98.49%. At the current price of SEK0.002, shares in ChromoGenics AB are trading at % against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
We were not able to find PE ratio data for ChromoGenics AB.
ChromoGenics AB's management team is headed by:
Here are the top five shareholders of ChromoGenics AB based on the size of their shareholding:
